Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found four distinct fibroblast types in human skin, which could help in treating wounds and fibrotic diseases.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Chemistry42 effectively creates and optimizes new molecules for drug discovery.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

Menstrual blood stem cell vesicles show promise for treating various medical conditions.

PandaOmics uses AI to find new disease treatment targets and biomarkers.

Microneedles can improve skin disease treatment by delivering drugs directly through the skin.

Extracellular vesicles show promise as treatments but need more research for safety and effectiveness.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Targeting macrophages may improve wound healing.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

Engineered extracellular vesicles can improve tissue repair and regeneration.

Biomimetic synthetic vesicles could improve precision medicine by combining natural and synthetic benefits.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Human mesenchymal stem cells show promise for treating skin diseases, but more research is needed to improve treatments.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Cold atmospheric plasma is a promising and safe treatment for various skin conditions.

Long COVID is complex, affects many survivors, and needs more research for effective treatments.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Dysplastic nevi have unique gene expressions, making them distinct from common melanocytic nevi.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Smart delivery methods for CRISPR gene editing are crucial for clinical success.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

Microneedles are promising for disease monitoring and drug delivery due to their minimal invasiveness and versatility.

A new mouse model effectively mimics vitiligo for research and drug testing.